
Baylink Presents New Preclinical Data At The American Association For Cancer Research (AACR) Annual Meeting
PALO ALTO, CA, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- Preclinical results for lead ADC candidate BLB-101 for Claudin 6/9+ tumors supports potential best-in-class profile. Data presented demonstrating Baylink’s innovative ADC …